These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 24670459)

  • 21. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.
    Menahem B; Lubrano J; Duvoux C; Mulliri A; Alves A; Costentin C; Mallat A; Launoy G; Laurent A
    Liver Transpl; 2017 Jun; 23(6):836-844. PubMed ID: 28295992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases].
    Zheng SS; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Wu J; Lu AW; Shao ZX
    Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):450-4. PubMed ID: 15854372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation is an alternative treatment of hepatocellular carcinoma beyond the Milan criteria.
    Fan HL; Chen TW; Hsieh CB; Jan HC; His SC; De-Chuan C; Chu CH; Yu JC
    Am J Surg; 2010 Aug; 200(2):252-7. PubMed ID: 20122677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.
    Sapisochin G; Castells L; Dopazo C; Bilbao I; Minguez B; Lázaro JL; Allende H; Balsells J; Caralt M; Charco R
    Ann Surg Oncol; 2013 Apr; 20(4):1194-202. PubMed ID: 22965574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
    Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.
    Kornberg A; Küpper B; Tannapfel A; Büchler P; Krause B; Witt U; Gottschild D; Friess H
    Liver Transpl; 2012 Jan; 18(1):53-61. PubMed ID: 21850692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cirrhosis and microvascular invasion predict outcomes in hepatocellular carcinoma.
    Barreto SG; Brooke-Smith M; Dolan P; Wilson TG; Padbury RT; Chen JW
    ANZ J Surg; 2013 May; 83(5):331-5. PubMed ID: 22943449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival.
    Poon RT; Fan ST; Lo CM; Liu CL; Wong J
    Ann Surg; 2007 Jan; 245(1):51-8. PubMed ID: 17197965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence rate and transplantability after liver resection in patients with hepatocellular carcinoma who initially met transplantation criteria.
    Tanaka H; Kubo S; Tsukamoto T; Shuto T; Takemura S; Yamamoto T; Okuda T; Kanazawa A; Hirohashi K
    Transplant Proc; 2005 Mar; 37(2):1254-6. PubMed ID: 15848687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies.
    Zheng Z; Liang W; Milgrom DP; Zheng Z; Schroder PM; Kong NS; Yang C; Guo Z; He X
    Transplantation; 2014 Jan; 97(2):227-34. PubMed ID: 24142034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation.
    Lee HS; Choi GH; Joo DJ; Kim MS; Choi JS; Kim SI
    Ann Surg Oncol; 2014 Aug; 21(8):2717-24. PubMed ID: 24916744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hangzhou criteria for liver transplantation in hepatocellular carcinoma: a single-center experience.
    Lei JY; Wang WT; Yan LN
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):200-4. PubMed ID: 23995766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatocellular carcinoma within Milan criteria and beyond: outcomes of liver transplantation in a single Argentinian institution].
    Gruz F; Cleres M; Raffa S; Yantorno S; Santilli JP; Vigliano C; Schelotto PB; Gondolesi GE; Descalzi V
    Acta Gastroenterol Latinoam; 2013 Jun; 43(2):106-12. PubMed ID: 23940910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization.
    Kamiyama T; Nakanishi K; Yokoo H; Kamachi H; Tahara M; Suzuki T; Shimamura T; Furukawa H; Matsushita M; Todo S
    Ann Surg Oncol; 2009 Jun; 16(6):1560-71. PubMed ID: 19259739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL; Zang YJ; Chen XG; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absolute lymphocyte count recovery at 1 month after transplantation predicts favorable outcomes of patients with hepatocellular carcinoma.
    Zheng Z; Lin B; Zhang J; Yang Z; Xie H; Zhou L; Zhang M; Zheng S
    J Gastroenterol Hepatol; 2015 Apr; 30(4):706-11. PubMed ID: 25238140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics.
    Dioguardi Burgio M; Ronot M; Fuks D; Dondero F; Cauchy F; Gaujoux S; Dokmak S; Paradis V; Durand F; Belghiti J; Vilgrain V
    Transplantation; 2015 Aug; 99(8):1613-8. PubMed ID: 25710611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.